Obstructive sleep apnea in patients with idiopathic normal-pressure hydrocephalus.
Tomoyuki Kawada
https://pubmed.ncbi.nlm.nih.gov/30640151Actively Recruiting
Led by University of Valencia · Updated on 2026-04-22
30
Participants Needed
1
Research Sites
39 weeks
Total Duration
Normal-pressure hydrocephalus is a condition in adults characterized by symptoms like gait problems, urinary incontinence, and dementia. This condition is linked to increased intracranial pressure during sleep, especially in relation to obstructive sleep apnea. Researchers are studying how sleep apnea affects intracranial and intra-abdominal pressures and how these pressures influence cerebrospinal fluid (CSF) shunting treatments. The study aims to determine the best type of shunt and drainage location to improve treatment outcomes and understand the interaction between sleep apnea and hydrocephalus symptoms. The study compares patients with normal-pressure hydrocephalus who have sleep apnea to those who do not. All participants receive a CSF shunt diversion procedure, where fluid is drained from the brain to either the abdominal cavity or the heart. Researchers will analyze pressure changes during sleep and sleep apnea episodes to decide which shunt type and drainage site are most effective. The study will also evaluate whether treating sleep apnea improves hydrocephalus symptoms. Participants will undergo assessments measuring changes in hydrocephalus symptoms using the Mini-Mental State Examination and the NPH scale within 1 to 2 months after CSF shunt insertion. The study monitors intracranial and intra-abdominal pressures during sleep, particularly during apnea episodes. This monitoring helps understand CSF flow dynamics at night and guides decisions on the type of shunt valve and drainage location. The total study duration and follow-up details are based on these evaluations to assess symptom changes and treatment impact.
CONDITIONS
Normal Pressure Hydrocephalus and Sleep Apnea
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 to 2 months
Participants receive a cerebrospinal fluid (CSF) shunt insertion to treat normal-pressure hydrocephalus and its symptoms.
1 baseline visit and follow-up visits during 1 to 2 months after shunt insertion
Total: 1 location
1
Vicente Vanaclocha
Valencia, Valencia, Spain, 46015
Actively Recruiting
V
Vicente Vanaclocha
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tomoyuki Kawada
https://pubmed.ncbi.nlm.nih.gov/30640151